Cargando…
Immunotherapy and Its Timing in Advanced Basal Cell Carcinoma Treatment
For patients with advanced basal cell carcinoma (BCC), including locally advanced or metastatic BCC not amenable to curative surgery or radiotherapy, hedgehog pathway inhibitors (HHI) vismodegib and sonidegib are approved as first-line systemic treatment. Results from clinical trials highlight that...
Autores principales: | Dessinioti, Clio, Stratigos, Alexander J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656142/ https://www.ncbi.nlm.nih.gov/pubmed/37992360 http://dx.doi.org/10.5826/dpc.1304a252 |
Ejemplares similares
-
Recent Advances in the Diagnosis and Management of High-Risk Cutaneous Squamous Cell Carcinoma
por: Dessinioti, Clio, et al.
Publicado: (2022) -
An Epidemiological Update on Indoor Tanning and the Risk of Skin Cancers
por: Dessinioti, Clio, et al.
Publicado: (2022) -
The Association of Nevus-Associated Melanoma with Common or Dysplastic Melanocytic Nevus: A Systematic Review and Meta-Analysis
por: Dessinioti, Clio, et al.
Publicado: (2023) -
Clinical and Dermoscopic Findings of Nevi after Photoepilation: A Review
por: Dessinioti, Clio, et al.
Publicado: (2023) -
Recent advances in understanding
Propionibacterium acnes (
Cutibacterium acnes) in acne
por: Platsidaki, Eftychia, et al.
Publicado: (2018)